Stay updated with breaking news from Tissue Based Products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published a warning letter issued to Akan Biosciences, Inc.
Center for Biologics Evaluation and Research and Food and Drug Administration FDA publish warning letter to Akan Biosciences for unresolved inspection observation
Thanks Stakeholders who Advocated for Patients...
An FDA workshop featuring regulators from around the world provided the regulatory perspective on how each government determines whether a biosimilar is clinically equivalent to their reference product, highlighting the science behind their development guidelines.
/PRNewswire/ -- The "Markets for Advanced Wound Management Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for AWM...